Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
ABCL
— AbCellera Biologics Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
FEB 24, 2026
REVENUE
$44.9M
+400.9%
NET MARGIN
-19.9%
+617.9 PTS
EPS
-$0.03
+84.2%
FREE CASH FLOW
-$44.6M
+27.5%
No summary has been written for this call yet.
← NEWER CALL
CALL 3 OF 4
OLDER CALL →